Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of €52.03 billion as of December 5, 2025. Its market cap has increased by 82.32% in one year.

Market Cap

52.03B

Enterprise Value

52.07B

Revenue

2.74B

Ranking

n/a

PE Ratio

1,401.18

Stock Price

€393.00

Market Cap Chart

Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 52.03B, an increase of 54,746.47%. That is a compound annual growth rate of 34.02%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	52.03B	77.47%
Dec 31, 2024	29.32B	34.90%
Dec 29, 2023	21.73B	-20.57%
Dec 30, 2022	27.36B	53.40%
Dec 31, 2021	17.83B	44.47%
Dec 31, 2020	12.34B	7.89%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Merck KGaA	52.46B
Siemens Healthineers AG	48.55B
Bayer Aktiengesellschaft	32.72B
Fresenius SE & Co. KGaA	26.96B
Sartorius Aktiengesellschaft	15.56B
Fresenius Medical Care AG	11.49B
Carl Zeiss Meditec AG	3.79B
Fielmann Group AG	3.60B

Market Cap Rankings